Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory
Pharma
Novo won't file for IcoSema approval in US
Novo won’t be able to submit its IcoSema application in the U.S. for the time being, thanks to a recent FDA rejection of its once-weekly insulin.
Fraiser Kansteiner
Aug 13, 2024 1:40pm
FDA proposes cell and gene therapy site tours
Jul 15, 2024 4:37pm
Trade group issues challenge to politicians ahead of UK election
Jun 11, 2024 2:30pm
See how the FDA's revamped hiring efforts are going
Aug 22, 2022 10:35am
FDA struggles persist as pandemic scuppers production oversight
Jun 16, 2022 10:45am
GSK, Vir's COVID antibody put on ice as BA.2 variant takes hold
Apr 5, 2022 3:42pm
